Swedish Orphan Biovitrum AB - Company Profile
Powered by
All the data and insights you need on Swedish Orphan Biovitrum AB in one report.
- Save hours of research time and resources with
our up-to-date Swedish Orphan Biovitrum AB Strategy Report
- Understand Swedish Orphan Biovitrum AB position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Swedish Orphan Biovitrum AB (Sobi) manufactures and sells specialist pharmaceuticals internationally. A broad product portfolio, research and development activities, improved operating performance are its major strengths, even as working capital deficit is a cause for concern. Market potential for Hemophilia, strategic agreement, and regulatory approvals and new product launches could provide growth opportunities to the company. However, growing parallel trade, stringent regulations and competitive pressure pose challenges to the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward